Is hypercholesterolemia a risk factor for Alzheimer's disease?
- PMID: 15953820
- DOI: 10.1385/MN:31:1-3:185
Is hypercholesterolemia a risk factor for Alzheimer's disease?
Abstract
There is considerable attention being given to the association of Alzheimer's disease and cholesterol homeostasis. To that end, some have suggested that elevated cholesterol levels are a risk factor for Alzheimer's disease. If elevated cholesterol is a risk factor for Alzheimer's disease, then it would be expected that patients with Alzheimer's disease would have elevated serum and brain cholesterol levels. Studies were reviewed that have examined cholesterol levels in Alzheimer's patients and control subjects, including prospective studies, and based on that review, the conclusion is reached that the majority of studies do not support elevated cholesterol levels in serum and brain as a risk factor for Alzheimer's disease. Alternative hypotheses are discussed, including cholesterol domains and subgroups of individuals with hypercholesteremia.
Similar articles
-
Oxysterols and Alzheimer's disease.Acta Neurol Scand Suppl. 2006;185:43-9. doi: 10.1111/j.1600-0404.2006.00684.x. Acta Neurol Scand Suppl. 2006. PMID: 16866910 Review.
-
Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.Psychiatr Danub. 2008 Jun;20(2):162-7. Psychiatr Danub. 2008. PMID: 18587285 Review.
-
Diet and Alzheimer's disease.Harv Ment Health Lett. 2003 Feb;19(8):4-7. Harv Ment Health Lett. 2003. PMID: 12604447 No abstract available.
-
Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease.J Am Geriatr Soc. 2007 Jan;55(1):133-5. doi: 10.1111/j.1532-5415.2006.01003.x. J Am Geriatr Soc. 2007. PMID: 17233704 No abstract available.
-
Should the guidelines for monitoring serum cholesterol levels in the elderly be re-evaluated?J Mol Neurosci. 2002 Aug-Oct;19(1-2):209-12. doi: 10.1007/s12031-002-0035-1. J Mol Neurosci. 2002. PMID: 12212783
Cited by
-
Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.Mol Neurobiol. 2021 May;58(5):2183-2201. doi: 10.1007/s12035-020-02232-6. Epub 2021 Jan 7. Mol Neurobiol. 2021. PMID: 33411241 Review.
-
Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy.J Alzheimers Dis. 2020;73(4):1305-1311. doi: 10.3233/JAD-191023. J Alzheimers Dis. 2020. PMID: 31929164 Free PMC article.
-
Lipid rafts in neurodegeneration and neuroprotection.Mol Neurobiol. 2014 Aug;50(1):130-48. doi: 10.1007/s12035-013-8614-4. Epub 2013 Dec 22. Mol Neurobiol. 2014. PMID: 24362851 Review.
-
The role of DHCR24 in the pathogenesis of AD: re-cognition of the relationship between cholesterol and AD pathogenesis.Acta Neuropathol Commun. 2022 Mar 16;10(1):35. doi: 10.1186/s40478-022-01338-3. Acta Neuropathol Commun. 2022. PMID: 35296367 Free PMC article. Review.
-
Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.J Neurochem. 2014 May;129(4):559-72. doi: 10.1111/jnc.12637. Epub 2014 Jan 2. J Neurochem. 2014. PMID: 24329875 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical